4//SEC Filing
VF High Conviction Fund 4
Accession 0001144204-17-065710
CIK 0001279695other
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 7:33 AM ET
Size
13.1 KB
Accession
0001144204-17-065710
Insider Transaction Report
Form 4
VF High Conviction Fund
10% Owner
Transactions
- Purchase
Common Stock
2017-12-27$0.29/sh+56,245$16,255→ 10,633,309 total - Purchase
Common Stock
2017-12-29$0.30/sh+750,318$225,095→ 11,434,001 total - Purchase
Common Stock
2017-12-22$0.27/sh+33,613$9,042→ 10,577,064 total - Purchase
Common Stock
2017-12-28$0.29/sh+50,374$14,810→ 10,683,683 total
Footnotes (7)
- [F1]Traded as Chess Depository Interests ("CDIs") on the Australian Stock Exchange. CDIs represent beneficial interests in the common stock held by CHESS Depository Nominees Pty Ltd.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.265 to $0.270, inclusive. The Reporting Person undertakes to provide to Universal Biosensors, Inc. ("UBI"), any security holder of UBI, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.275 to $0.300, inclusive. The Reporting Person undertakes to provide to Universal Biosensors, Inc. ("UBI"), any security holder of UBI, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.290 to $0.300, inclusive. The Reporting Person undertakes to provide to Universal Biosensors, Inc. ("UBI"), any security holder of UBI, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions all at a price of $0.300. The Reporting Person undertakes to provide to Universal Biosensors, Inc. ("UBI"), any security holder of UBI, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5) to this Form 4.
- [F6]The price per share of the common stock reported is stated in Australian dollars, as converted from a U.S. dollar price on the date of the transaction.
- [F7]The common stock is directly held by VF High Conviction Fund ("Conviction Fund") and indirectly held by Viburnum Funds Pty Ltd ("Viburnum"), the manager of Conviction Fund, and the individual directors of Viburnum (Viburnum and the individual directors together, the "Viburnum Indirect Reporting Persons"). The individual directors of Viburnum are Craig Coleman, Marshall Allen, Anthony Howarth and Melissa Karlson. The Viburnum Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the Conviction Fund common stock in which the Viburnum Indirect Reporting Persons have no pecuniary interest.
Documents
Issuer
UNIVERSAL BIOSENSORS INC
CIK 0001279695
Entity typeother
IncorporatedAustralia
Related Parties
1- filerCIK 0001679282
Filing Metadata
- Form type
- 4
- Filed
- Dec 28, 7:00 PM ET
- Accepted
- Dec 29, 7:33 AM ET
- Size
- 13.1 KB